Trial
NCT04887935
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
The Foundation for Barnes-Jewish Hospital; Swim Across America
Condition
Prostate Cancer
Intervention
Dapagliflozin
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30